25-web-images/img_02_02_opt.jpeg)
Figure 2. Relapse rate reduction vs oral FGA according to class and administration frequency
Farmeconomia. Health economics and therapeutic pathways 2019; 20(1): 25
https://doi.org/10.7175/fe.v20i1.1406
Original Research
Erratum: Effectiveness of Long Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations
Published: 13 February 2019
Zaniolo O, Ghetti G, Povero M, Pradelli L. Effectiveness of Long-Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations. Farmeconomia. Health economics and therapeutic pathways 2019; 20: 13-24; https://doi.org/10.7175/fe.v20i1.1393
There was an error in the relapse rate reduction reported in Figure 2 in this article by Zaniolo et al. [Farmeconomia. Health economics and therapeutic pathways 2019; 20: 13-24; https://doi.org/10.7175/fe.v20i1.1393]. The online version has been corrected on 13 February 2019, as shown below:
Figure 2. Relapse rate reduction vs oral FGA according to class and administration frequency
We apologize for any inconvenience caused.